Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.22.2.2
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2022
Dec. 31, 2021
Current assets:    
Cash and cash equivalents $ 6,309 $ 2,672
Restricted cash 250
Accounts receivable 4,792 4,672
Other current assets 1,610 1,479
Current assets of discontinued operations 28 3,093
Total current assets 12,739 12,166
Property and equipment, net 428 317
Other intangible assets, net 1,179 2,132
Operating lease right of use assets 867 1,284
Other long-term assets 80 141
Long-term assets of discontinued operations 22,387
Total assets 15,293 38,427
Current liabilities:    
Accounts payable 1,446 1,374
Accrued salary and bonus 1,631 2,689
Other accrued expenses 8,375 8,462
Line of credit - current 2,500
Current liabilities of discontinued operations 858 3,157
Total current liabilities 14,810 15,682
Contingent consideration 632 1,383
Operating lease liabilities, net of current portion 184 520
Line of credit 1,500
Note payable at fair value 9,988 7,942
Other long-term liabilities 4,736 4,577
Long-term liabilities of discontinued operations 2,705
Total liabilities 30,350 34,309
Commitments and contingencies (Note 9)
Redeemable preferred stock, $.01 par value; 5,000,000 shares authorized, 47,000 shares Series B issued and outstanding 46,536 46,536
Stockholders’ deficit:    
Common stock, $.01 par value; 100,000,000 shares authorized; 4,293,666 and 4,228,169 shares issued, respectively; 4,246,297 and 4,195,412 shares outstanding, respectively 404 403
Additional paid-in capital 187,390 186,106
Accumulated deficit (247,453) (227,059)
Treasury stock, at cost (47,369 and 32,757 shares, respectively) (1,934) (1,868)
Total stockholders’ deficit (61,593) (42,418)
Total liabilities and stockholders’ deficit (31,243) (8,109)
Total liabilities, preferred stock and stockholders’ deficit $ 15,293 $ 38,427